Global Self-amplifying RNA (saRNA) Drugs Supply, Demand and Key Producers, 2024-2030
The global Self-amplifying RNA (saRNA) Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
saRNA is an RNA that shares many structural similarities with mRNA: it is a linear, single-stranded RNA molecule synthesized from a 5' cap, a 3' poly(A) tail, and 5' and 3' UTRs. The main difference is that saRNA is a larger molecule because it encodes four additional proteins in addition to the vaccine antigen or gene of interest. These four additional proteins are nonstructural proteins, usually derived from alphaviruses, encoding replicase enzymes. This replicase is able to amplify the original RNA strand upon delivery to cells, resulting in higher amounts of protein expression with minimal RNA dosage required.
This report studies the global Self-amplifying RNA (saRNA) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Self-amplifying RNA (saRNA) Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Self-amplifying RNA (saRNA) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Self-amplifying RNA (saRNA) Drugs total production and demand, 2019-2030, (K Units)
Global Self-amplifying RNA (saRNA) Drugs total production value, 2019-2030, (USD Million)
Global Self-amplifying RNA (saRNA) Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Self-amplifying RNA (saRNA) Drugs domestic production, consumption, key domestic manufacturers and share
Global Self-amplifying RNA (saRNA) Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Self-amplifying RNA (saRNA) Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna and CSL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Self-amplifying RNA (saRNA) Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Self-amplifying RNA (saRNA) Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Self-amplifying RNA (saRNA) Drugs Market, Segmentation by Type
Preventive Medicine
Medicine
Global Self-amplifying RNA (saRNA) Drugs Market, Segmentation by Application
Infectious Disease
Cancer
Others
Companies Profiled:
Chimeron Bio
Ziphius Vaccines
Aldevron
VaxEquity
Precision Nanosystems
Replicate Bioscience
Elixirgen Therapeutics
Immorna
CSL
Arcturus Therapeutics
Key Questions Answered
1. How big is the global Self-amplifying RNA (saRNA) Drugs market?
2. What is the demand of the global Self-amplifying RNA (saRNA) Drugs market?
3. What is the year over year growth of the global Self-amplifying RNA (saRNA) Drugs market?
4. What is the production and production value of the global Self-amplifying RNA (saRNA) Drugs market?
5. Who are the key producers in the global Self-amplifying RNA (saRNA) Drugs market?